TAOK1
Official symbol: | TAOK1 |
Full name: | TAO kinase 1 |
Location: | 17q11.2 |
Also known as: | MARKK, FLJ14314, KIAA1361, PSK2, TAO1, MAP3K16 |
Entrez ID: | 57551 |
Ensembl ID: | ENSG00000160551 |
Summary: | |
|
Overall distribution
|
|
Tissue specific distribution
|
|
|
|
|
|
|
|
|
|
Overall distribution
|
|
Tissue specific distribution
|
|
Gscore (Amp): | 0.28 | Gscore (Del): | 0.00 |
|
|
Recurrently amplified in 1 cancer type(s) |
|
|
|
|
|
|
Overall distribution
|
|
Tissue specific distribution
|
|
|
|
Recurrently mutated in 1 cancer type(s) |
|
|
|
|
|
|
Overall
|
|
Tissue specific
|
|
Total fusion occurrence: | 20 (Driver) |
|
|
Fusions detected in 12 cancer type(s) |
|
|
|
|
|
Functional class: | Kinase (protein kinase) |
JensenLab PubMed score: | 36.87 (Percentile rank: 57.48%) |
PubTator score: | 19.66 (Percentile rank: 51.96%) |
Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
Tractability (antibody): | |